Platelet glycoprotein IIb/IIIa receptor blockade and low-dose hepa- rin during percutaneous coronary revascularization. The EPILOG Investigators. N Engl J Med. 1997;336:1689 96. 380. Boersma E,Akkerhuis KM, Theroux P, et al. Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention. Circulation. 1999;100:2045 8. 381. Hamm CW, Heeschen C, Goldmann B, et al. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. N Engl J Med. 1999;340:1623 9. 382. Use of a monoclonal antibody directed against the platelet glycopro- tein IIb/IIIa receptor in high-risk coronary angioplasty. The EPIC Investigation. N Engl J Med. 1994;330:956 61. 383. Valgimigli M, Percoco G, Barbieri D, et al. The additive value of tirofi- ban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty: the ADVANCE Trial. J Am Coll Cardiol. 2004;44:14 9. 384. Novel dosing regimen of eptifibatide in planned coronary stent implanta- tion (ESPRIT): a randomised, placebo-controlled trial. Lancet. 2000;356: 2037 44. 385. Peters RJ, Mehta SR, Fox KA, et al. Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to pre- vent Recurrent Events (CURE) study. Circulation. 2003;108:1682 7. 386. Serebruany VL, Steinhubl SR, Berger PB, et al. Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials. Am J Cardiol. 2005; 95:1218 22. 387. Steinhubl SR, Bhatt DL, Brennan DM, et al. Aspirin to prevent cardio- vascular disease: the association of aspirin dose and clopidogrel with thrombosis and bleeding. Ann Intern Med. 2009;150:379 86. 388. 